Pooled analysis using the random effects model demonstrated that metformin treatment significantly reduced AMH levels in PCOS patients (SMD -0.70, 95% CI -1.13 to -0.28, P = 0.001). This evidence concerns the gene AMH and polycystic ovary syndrome.